EUVIMEDEUVIMED entdecken
Open Access

Dihydromyricetin Inhibits Ferroptosis to Attenuate Cisplatin-Induced Muscle Atrophy

L You

Physiological Research · 2024

DOI: 10.33549/physiolres.935317 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Physiological Research, 2024. Verfasst von L You. Beteiligte Einrichtung: The Second Affiliated Hospital, Department of Clinical Pharmacy, Hengyang Medical School, University of South China, Hengyang, Hunan, China. youlijia…. Hauptthemen laut MEDLINE: Flavonols, Muscular Atrophy, Ferroptosis, Mice, Inbred C57BL. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cisplatin is a widely used chemotherapy drug for the treatment of various cancers. However, although cisplatin is effective in targeting cancer cells, it has severe side effects including skeletal muscle atrophy. In this study, we aimed to characterize the role of Dihydromyricetin in cisplatin-induced muscle atrophy in mice. 5-week-old male C57BL/6 mice were treated with Dihydromyricetin for 14 days orally followed by in intraperitoneally cisplatin administration for 6 days. Gastrocnemius muscles were isolated for the following experiments. Antioxidative stress were determined by peroxidative product malondialdehyde (MDA) and antioxidants superoxide dismutase (SOD) and glutathione peroxidase (GPx) activities. Quadriceps muscle mass and grip strength were significantly restored by Dihydromyricetin in a dose-dependent manner. Moreover, muscle fibers were improved in Dihydromyricetin treated group. Excessive skeletal muscle E3 ubiquitin-protein ligases in cisplatin group were significantly repressed by Dihydromyricetin treatment. Dihydromyricetin significantly reduced oxidative stress induced by cisplatin by decreasing MDA level and restored SOD and GPx activities. In addition, ferroptosis was significantly reduced by Dihydromyricetin characterized by reduced iron level and ferritin heavy chain 1 and improved Gpx4 level. The present study demonstrated that Dihydromyricetin attenuated cisplatin-induced muscle atrophy by reducing skeletal muscle E3 ubiquitin-protein ligases, oxidative stress, and ferroptosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FlavonolsMuscular AtrophyFerroptosisMice, Inbred C57BLCisplatinOxidative StressAnimalsMaleMiceMuscle, SkeletalAntineoplastic AgentsAntioxidants

Substanzen

dihydromyricetinFlavonolsCisplatinAntineoplastic AgentsAntioxidants

Autor:innen und Institutionen

  • The Second Affiliated Hospital, Department of Clinical Pharmacy, Hengyang Medical School, University of South China, Hengyang, Hunan, China. youlijiang1988@163.com.

Zitieren

APA

You, L. (2024). Dihydromyricetin Inhibits Ferroptosis to Attenuate Cisplatin-Induced Muscle Atrophy. Physiological Research. https://doi.org/10.33549/physiolres.935317

Vancouver

You L. Dihydromyricetin Inhibits Ferroptosis to Attenuate Cisplatin-Induced Muscle Atrophy. Physiological Research. 2024. doi:10.33549/physiolres.935317

BibTeX
@article{You2024,
  author = {You, L},
  title = {Dihydromyricetin Inhibits Ferroptosis to Attenuate Cisplatin-Induced Muscle Atrophy},
  journal = {Physiological Research},
  year = {2024},
  doi = {10.33549/physiolres.935317}
}
Kostenlos starten →